Stem Cell Pioneers: iPSC Discovery, Potential, and Manufacturing, Interview with Dr. Koji Tanabe
Dr. Koji Tanabe discusses IPS cell advancements, mass manufacturing, and their future in medicine.
Manufacturing
Japan and Belgium Partner Up to Promote Regenerative Nanobiotech
The Japanese Society for Regenerative Medicine and imec will jointly pursue nanobiotechnology for regen med applications.
STEMCELL Technologies Acquires Cellular Highways to Enhance Cell Sorting Technology
The acquisition is expected to help expand its cell therapy capabilities, gaining advanced microfluidic cell sorting tech for enhanced research
CellProthera Selects CELLforCURE to Manufacture Stem Cells for Phase 3 Heart Failure Study
CellProthera is gearing up for Phase 3 cardiac regeneration trials, moving one step closer to producing clinical batches of ProtheraCytes®, it's stem cell candidate
NurExone reports enhanced scalability and clinical readiness for upcoming exosome-based clinical trials for neurological conditions
The Israeli regenerative medicine company is moving one step closer to clinical trials for serious neurological indications such as TBI, spinal cord injury, etc.
TreeFrog Therapeutics nabs €30M in funding to accelerate its iPSC technology, planning Parkinson’s trial in 2027
TreeFrog has developed a proprietary iPSC manufacturing process called C-Stem, moving one step closer to human trials.
Organogenesis to open $100M biotech facility in Rhode Island, will resume Dermagraft production
The company will produce its FDA-approved diabetic foot ulcer product and others at the new facility, creating over 200 full-time jobs.
Cellino’s iPSC Manufacturing Tech Receives FDA Advanced Manufacturing Technology (AMT) Designation
With this designation secured, Cellino is looking to accelerate the commercialization of personalized regenerative therapies.
I Peace brings Japanese industrial-scale iPSC production to the USA, reporting lower production cost
The company has brought its Japanese manufacturing technology to the USA, and claims this will help provide much biologically younger cell therapies to Americans.
Thermo Fisher Scientific launches new cell therapy development center in San Diego
The new Carlsbad facility will provide researchers with critical tools, expertise, and support to rapidly advance cell therapies toward clinical manufacturing.